About Us

Investor Relations

Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory and allergy therapies.

Recent Releases

Nov 18, 2009
Mylan's President of Europe, Middle East and Africa Elected President of European Generic Medicines Association

Nov 12, 2009
Mylan's Spanish Business Named Best Generic Pharmaceuticals Company in Spain by Elsevier

View all releases »

Stock Chart
Stock price graph
3 Mo.   6 Mo.   1 Yr.
Stock Quote
Mylan (NASDAQ: MYL)
Price: 17.55
Change: + 0.12
Day High: 17.63
Day Low: 17.31
Volume: 4,080,200
Delayed at least 20 minutes.
Provided by eSignal.